Barinthus Biotherapeutics (BRNS) Times Interest Earned (2020 - 2025)
Historic Times Interest Earned for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$1158.9.
- Barinthus Biotherapeutics' Times Interest Earned fell 11003.94% to -$1158.9 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1647.6, marking a year-over-year decrease of 2248.3%. This contributed to the annual value of -$1282.5 for FY2024, which is 5720.78% up from last year.
- As of Q3 2025, Barinthus Biotherapeutics' Times Interest Earned stood at -$1158.9, which was down 11003.94% from -$1943.7 recorded in Q2 2025.
- In the past 5 years, Barinthus Biotherapeutics' Times Interest Earned registered a high of $8.84 during Q1 2022, and its lowest value of -$2855.4 during Q4 2023.
- Over the past 5 years, Barinthus Biotherapeutics' median Times Interest Earned value was -$1523.8 (recorded in 2024), while the average stood at -$1390.6.
- Its Times Interest Earned has fluctuated over the past 5 years, first crashed by 2519124.88% in 2021, then surged by 47946.0% in 2022.
- Over the past 5 years, Barinthus Biotherapeutics' Times Interest Earned (Quarter) stood at -$926.0 in 2021, then soared by 100.95% to $8.84 in 2022, then crashed by 32409.13% to -$2855.4 in 2023, then soared by 31.74% to -$1949.2 in 2024, then surged by 40.54% to -$1158.9 in 2025.
- Its last three reported values are -$1158.9 in Q3 2025, -$1943.7 for Q2 2025, and -$1584.6 during Q1 2025.